and this bacterial homolog. In particular, it is not known which residues directly bind bile salts when ASBT is confi gured in an outward direction to accept substrates for uptake.
In this report, we have characterized two ASBT orthologs at the molecular and functional level that represent early stages in the vertebrate lineage. First, we identifi ed an ASBT ortholog in the sea lamprey ( Petromyzon marinus ), representing agnathans, the most primitive vertebrate class that diverged from a more complex lineage ‫ف‬ 500 million years ago and whose bile consists of some of the earliest 5 ␣ -C27 bile alcohols. Second, we identifi ed an ASBT ortholog in the little skate ( Leucoraja erinacea ), an early gnathostome that diverged ‫ف‬ 300 million years ago, whose bile salts are 5 ␤ -C27 bile alcohols ("intermediate" bile salts). Finally, we compared our fi ndings with the structure and substrate specifi city of ASBT from humans, whose bile contains the later evolving 5 ␤ -C24 bile acids. Our phylogenetic and experimental fi ndings support the concept that ASBT emerged at the very beginning of vertebrate evolution with a limited ability to transport bile salts. As vertebrate evolution progressed, the substrate specifi city of ASBT/Asbt for bile salts expanded while at the same time retaining its ability to transport the earlier evolved forms. These fi ndings also indicate that the enterohepatic circulation of bile salts is a conserved function throughout vertebrate evolution. structure to the four conjoined steroid rings, one that is similar to that of cholesterol ( 1, 11 ) . Evolutionarily "intermediate" 5 ␤ -C27 sulfated bile alcohols in which the four rings of the steroid possess a tilted structure are mostly detected in jawed cartilaginous fi shes (early gnathostomes). More complex vertebrates including mammals primarily use later evolving bile salts, which are 5 ␤ -C24 bile acid conjugates with a bent ring juncture and a shortened side chain containing a carboxylic acid. Because of these structural changes, bile salt composition has been proposed as a complementing biochemical trait to characterize evolutionary relationships among species ( 1 ) .
The major structural variation of bile salts seen over the course of vertebrate evolution raises the question as to how the various transporters that move bile salts into and out of cells located in the intestine and liver have adapted to these changes. Specifi cally, do nonmammalian Slc10a2's in more primitive species function as Na +dependent bile salt transporters and how have they adapted structurally and functionally with the changing shapes of bile salts? Insight into the structure/function relationship of SLC10A/Slc10a members has been advanced by solving the crystal structure of a distant ASBT homolog from the bacterium Neisseria meningitidis ( 15 ) . Still, the structural determinants of ASBT/Asbt for its bile salt substrates remain unclear because of low homology in the substrate binding pocket between ASBT/Asbt Fig. 1 . The structural change of bile salts during vertebrate evolution. A simplifi ed phylogenetic tree of vertebrate classes is shown, with respective major bile salt class indicated above, where dashed lines represent the molecular evolution of bile salts. Bile salts are metabolites of cholesterol, a versatile molecule that is already seen in invertebrates that do not use bile salts. Agnathans (jawless fi sh) are the earliest vertebrate class that primarily use "ancient" 5 ␣ -C27 sulfated bile alcohols with an overall planar structure as cholesterol, such as 5 ␣ -cyprinol sulfate. Of note, the bile salt spectrum of lamprey comprises a mixture of C27-and C24-5 ␣ sulfated bile alcohols that includes C24 5 ␣ -Petromyzonol sulfate (5 ␣ -PZS), a bile alcohol similar to 5 ␣ -cyprinol sulfate but with a shortened side-chain. The evolutionarily more advanced early gnathostomes (jawed cartilaginous fi sh) mostly use 5 ␤ -C27 sulfated bile alcohols with a tilted structure of the steroid rings, such as scymnol sulfate, the major bile salt of skate. As evolution further progressed, more complex vertebrates including mammals mostly use 5 ␤ -C24 bile acids with a shortened side-chain containing a carboxylic acid, such as taurocholic acid, a major bile salt in humans.
Molecular cloning
To clone lamprey Asbt (lpAsbt), we fi rst retrieved sequence fragments from the lamprey genome by ortholog searching using human ASBT (hASBT) protein sequence as query. We then designed primers and amplifi ed a 600 bp fragment from lamprey intestine using RT-PCR. DNA sequencing and phylogenetic analysis confi rmed that this fragment encoded a portion of lpAsbt. A full-length lpAsbt was obtained by 5 ′ -and 3 ′ -RACE PCR using a kit from Clontech. To clone skate Asbt (skAsbt), we fi rst acquired a DNA fragment by RT-PCR using degenerate primers that matched two conserved regions of ASBT/Asbts. The full-length skAsbt was also obtained by RACE PCR. To obtain hASBT, we directly amplifi ed the coding region from Caco-2 cells and inserted it into a pcDNA3 vector, and confi rmed sequence identity with GenBank data. To functionally characterize lpAsbt and skAsbt, both were also subcloned into pcDNA3 vectors. For both lpAsbt and skAsbt, at least six full-length clones were sequenced and one clone with identical sequence to the lamprey genome or original RACE-PCR products was picked for further experiments. In addition, we made lpAsbt-FLAG and skAsbt-FLAG constructs in pcDNA3 vectors to tag these two proteins at the C terminus for purposes of Western blotting and immunofl uorescent labeling. The primers are listed in supplementary Table I .
Phylogenetic analysis
Sequence alignment was performed with the ClustalW2 algorithm assuming the Gonnet replacement matrix ( 18 ) . We inferred phylogeny with Bayesian Markov Chain Monte Carlo (MCMC) analysis using MrBayes v3.2.0 software ( 19 ) . The analysis was performed assuming the Jones model for amino acid replacement, an equal rates ␥ distribution with four categories and run for 300,000 generations with one cold chain and three heated chains. Posterior probabilities were calculated by sampling every 100 generations and discarding the fi rst 500 samples as "burn-in". The phylogenetic tree was rooted using SLC17A5 as an out-group and visualized with FigTree v1.3.1. 3 H-TCA uptake assay COS-7 cells were maintained at low passage number in growth medium (DMEM with 10% FBS, 50 U/ml penicillin and 50 µg/ml streptomycin, all from Invitrogen). When cells reached 80% confl uence, they were transfected with either pcDNA3 (control), pcDNA3-lpAsbt, pcDNA3-skAsbt or pcDNA3-hASBT using Fugene HD or X-tremeGENE 9 transfection reagent (Roche). Forty hours posttransfection, cells were subjected to the uptake assay as previously described ( 20 ) . Transport activity was normalized to total cell protein. Kinetic constants are expressed as value ± SE and were calculated by nonlinear fi tting of data to the Michaelis-Menten equation using least squares (Graphpad Prism 5, Graphpad Software).
COS-7 cell based

ASBT-farnesoid X receptor ␣ (FXR/NR1H4) luciferase reporter assay for bile salt transport
A dual-luciferase gene reporter assay (Promega, Madison, WI) was utilized to assess the ability of conjugated bile salts to be transported into cells transfected with ASBT/Asbt's. HEK293T cells were maintained in growth medium. When cells reached 80% confl uence, the culture medium was changed to DMEM supplemented with 0.5% charcoal-stripped FBS and cotransfected with 50 ng pcDNA3 (control) or 4 ng pcDNA3-lpAsbt and 46 ng pcDNA3 or 50 ng pcDNA3-skAsbt or 50 ng pcDNA3-hASBT, along with 50 ng pCMX-hFXR ␣ , 37.5 ng pCMX-hRXR ␣ , 125 ng pGL3-hIBABP, and 1.5 ng phRL-CMV in triplicates, using 3 l Lipofectamine 2000 (Invitrogen) for each well in 24-well plates. Twenty-four hours posttransfection, cells were treated with bile
MATERIALS AND METHODS
Chemicals
Unless otherwise stated, all chemicals were from Sigma (St. Louis, MO). 3 
Animals
All animal experiments were performed at the Mount Desert Island Biological Laboratory (MDIBL) in Salisbury Cove, ME. Animal experiments were approved by the Institutional Animal Care and Use Committee and in concordance with the Public Health Service Policy on Humane Care and Use of Laboratory Animals. Larval lampreys were acquired from Acme Lamprey Co. (Harrison, ME). Adult lampreys were caught while migrating upstream in the Kennebunk River, Maine, in May-June 2011. Larval and adult lampreys were kept in dark-adapted freshwater tanks at 11°C. Skates were collected in June-July 2010 from the Gulf of Maine, off Biddeford, and maintained in seawater tanks at 15°C.
Everted gut sac 3 H-TCA uptake assay
All animals were anesthetized with Tricaine before euthanasia. The intestine was removed proximally at the liver or bile duct junction and distally at the start of the rectum. Proximal and distal everted gut sacs were prepared as described by Lack and Weiner ( 16 ) . Gut sacs were washed four times in either lamprey Ringer's solution (130 mM NaCl, 2.1 mM KCl, 1.8 mM MgCl 2 , 2.6 mM CaCl 2 , 1 mM NaHCO 3 , 4 mM D-glucose, 4 mM HEPES, tetramethylammonium hydroxide to pH 7.4) or elasmobranch Ringer's solution, prepared as described previously ( 17 ) . Next, all sacs were submerged in their respective solutions supplemented with 50 µM 3 H-TCA (1 mCi/mmol), lightly gassed with ambient air, and incubated at 15°C water bath for 30, 60, or 120 min with gentle manual agitation. Following incubation, sacs were washed four times in icecold solution, homogenized, and lysed in 0.5% Triton X-100 PBS. Lysate was centrifuged at 18,000 g for 10 min and supernatant collected for measurement of protein and radioactivity. Protein concentration was determined according to the Bradford method using a commercial kit (Bio-Rad). Radioactivity was measured in a Tri-Carb 2100TR liquid scintillation counter (Packard) and data was normalized to total cell protein.
RNA extraction and quantifi cation
Total RNA was isolated using TRIzol reagent (Invitrogen, Carlsbad, CA) and purifi ed using a kit (RNeasy Clean-up Kit, Qiagen, Valencia, CA). Two micrograms of total RNA from each sample was reverse transcribed into cDNA using a kit from Roche (Indianapolis, IN). TaqMan real-time RT-PCR was performed on an ABI 7500 Sequence Detection System (Applied Biosystems, Carlsbad, CA). The specifi c primers and probes are listed in supplementary Table I . Because the expression of the housekeeping gene ␤ -actin varied signifi cantly in the broad range of tissues that were examined, we normalized mRNA expression to 1 µg of total RNA. Results were expressed in copy number, where the cloned constructs were used to establish a standard curve.
that is believed to share the last common ancestor with vertebrates, produced 16 putative protein sequences that could be members of the Slc10 protein family. However, phylogenetic analysis did not identify a potential ortholog of SLC10A2 ( Fig. 3 and supplementary Figure I ). The salts for an additional 24 h in 0.5% charcoal-stripped FBS DMEM. Passive lysis buffer (Promega) was used to prepare cell lysate and luminescence was detected in a Synergy2 Microplate Reader (BioTek). Firefl y luciferase readings were normalized to Renila luciferase, the internal control. To validate the bile salt transport function of lpAsbt, cells were treated with lipid extract (1:1000 dilution) isolated from adult lamprey liver.
Statistical analysis
Statistical analysis was performed with Graphpad Prism 5 (Graphpad Software). Unpaired two-tailed t -test was used to detect differences between two groups and one-way ANOVA was used to detect differences between more than two groups, followed by Tukey's post hoc test for pairwise comparison. P < 0.05 was considered to be statistically signifi cant.
RESULTS
An intestinal Na + -dependent transport system for the modern bile salt TCA is absent in lamprey in contrast to the little skate
Previous work by our group demonstrated that bile salts are reabsorbed from the intestine of the little skate, suggesting that an active transport system is present for bile salts ( 21 ) . However, it was not known if this transport system is Na + -dependent, as is human and rodent ASBT/ Asbt. To address this question, 3 H-TCA uptake was assessed in everted gut sacs isolated from the little skate ( 16 ) . As demonstrated in Fig. 2A , a signifi cant time-dependent uptake of 3 H-TCA was observed in the distal but not proximal intestine. When Na + was replaced by choline in the medium, uptake of 3 H-TCA was abolished, indicating that a Na + -dependent bile salt transporter was present in the distal intestine of skate. A similar transport experiment was then carried out in adult lamprey, and in contrast to skate intestine, neither the proximal nor distal intestine of the lamprey showed signifi cant Na + -dependent uptake of 3 H-TCA ( Fig. 2B ). This negative result suggests that either an ASBT ortholog has not evolved in lamprey or its substrate specifi city is limited and does not accommodate the modern bile salt TCA.
ASBT orthologs are identifi ed in the distal intestine of both lamprey and skate
A search of the lamprey genome revealed DNA sequences with the potential to encode portions of an ASBT ortholog. Subsequent RT-PCR and RACE PCR identifi ed a full-length lpAsbt transcript which encodes 363 amino acids with a 132 bp 5 ′ -untranslated region (UTR) and 1.7 kb 3 ′ -UTR (GenBank accession number JX014266). To identify skAsbt, we performed RT-PCR using degenerate primers, followed by RACE PCR. We amplifi ed a full-length skAsbt transcript 2.3 kb in size, encoding for 393 amino acids with 189 bp at the 5 ′ -UTR and 918 bp at the 3 ′ -UTR (GenBank accession number JX014267). LpAsbt and skAsbt share 58% and 64% amino acid identity to hASBT, respectively (supplementary Table II ). Phylogenetic analysis placed lpAsbt and skAsbt as the most primitive of known ASBT/SLC10A2 orthologs ( Fig. 3 ). BLAST search of genome of the sea squirt ( Ciona intestinalis ), an invertebrate 
Affi nity for the modern bile salt TCA is absent in lpAsbt, low in skAsbt, and high in hASBT
To functionally characterize lpAsbt and skAsbt and to compare their substrate specifi city to hASBT, we subcloned these three genes into a pcDNA3 plasmid vector and transfected them into COS-7 cells for expression. As shown in Fig. 5A , skAsbt and hASBT demonstrated Na + -dependent uptake of 10 µM 3 H-TCA that increased signifi cantly over vector control. In contrast, lpAsbt did not show any specifi c transport activity for 3 H-TCA (10-100 µM) with or without Na + in the media, despite confi rmation by Western blot and immunofl uorescent labeling that the lpAsbt-FLAG fusion protein was expressed on the plasma membrane of transfected cells (supplementary Fig. IV) . These results are consistent with the negative results of 3 H-TCA transport in the everted gut sac experiments ( Fig. 2B ) and suggest that either lpAsbt is not a functional bile salt transporter or it is functionally inactive for the modern 5 ␤ -C24 bile salt TCA.
Michaelis-Menten analysis of 3 H-TCA transport kinetics indicated that skAsbt has a V max of 75 ± 9 pmol/mg protein/min with a K m of 99 ± 24 µM, whereas hASBT has a V max of 51 ± 3 pmol/mg protein/min with a signifi cantly lower K m of 13 ± 2 µM ( Fig. 5B ). Of note, the V max was derived from data normalized to total protein in transfected cells, not to transporter protein, which prevents direct comparison between absolute transport rates and subsequently comparison of V max . However, K m is independent of absolute transport rate, and can be compared to determine differences in affi nity. The fi ndings of lack of TCA affi nity for lpAsbt and low affi nity for skAsbt, albeit lower than for hASBT, suggest that structural changes in Asbt have evolved that allowed accommodation of this new bile acid structure sometime between the development of agnathans and early gnathostomes, whereas TCA affi nity was optimized further between early gnathostome and mammalian evolution.
ciona sequence that was most closely related was placed on the common branch of Slc10a2 and Slc10a6 subfamilies. Based on these fi ndings, we propose that a distinct Asbt/Slc10a2 fi rst emerged from an ancient Slc10a2/a6like gene near the beginning of vertebrate evolution, presumably from a gene duplication between ciona and lamprey evolution, at a time that coincides with the extensive utilization of cholesterol, the emergence of bile salts, the development of a biliary system and the ability to produce bile.
Alignment of experimentally verifi ed sequences of ASBT/Asbt's revealed that the proposed transmembrane domains are well conserved, including the Na + -binding core and the substrate binding pocket based on the recently solved crystal structure of a distant ASBT homolog in N. meningitidis ( 15 ) (supplementary Figs. II and III). In contrast, the sequences of the N-terminus and C terminus show great interspecies variation. For example, while a N-glycosylation site in hASBT Asn-10 is well conserved ( 22 ) , computer software predicts an additional N-glycosylation site at Asn-22 in skAsbt (supplementary Fig. II) .
To determine the tissue distribution of lpAsbt and skAsbt, we performed real-time RT-PCR. As shown in Fig. 4A , lpAsbt mRNA was expressed primarily in the kidney and intestine; less in testes, heart, and brain; and was undetectable in muscle, gill, and liver. A similar expression pattern was found in lamprey larva. SkAsbt mRNA was highly expressed in the intestine with lower levels in the kidney, gallbladder, and rectal gland; it was absent from other tissues ( Fig. 4C ). In addition, we analyzed mRNA distribution along segments of intestine, which demonstrated that both lpAsbt and skAsbt are most abundant in the distal intestine ( Fig. 4B, D ) . This was particularly evident in skate with a greater than 300-fold expression in the distal compared with the proximal intestine. These expression profi les are similar in human and rodents and correspond with the known bile salt recycling function of ASBT. Fig. 4 . Tissue distribution of lpAsbt and skAsbt mRNA by quantitative real-time RT-PCR. A broad variety of tissues was tested for mRNA expression of lpAsbt (A) and skAsbt (C). Expression along the intestine was determined by dividing the intestine in 7 segments of equal length (B and D). Segment 1 starts at the intestinal connection to the bile duct/liver and segment 7 ends at the start of the rectum. Expression below 1,000 copies mRNA/ g total RNA was considered background and is not shown. All values represent one animal and are expressed as means from triplicate measurements. for 5 ␣ -PZS. When 5 ␤ -C27 scymnol sulfate was tested, lpAsbt showed signifi cant activity only at 25 µM or higher concentrations whereas skAsbt and hASBT demonstrated activity with nanomolar concentrations ( Fig. 6B ) . When cells were treated with 5 ␤ -C24 TCA, lpAsbt did not show any transport activity, skAsbt showed low activity, whereas hASBT showed high activity ( Fig. 6C ) . To further confi rm that lpAsbt, skAsbt, and hASBT have differential selectivity for bile salts, we tested additional early and late evolving bile salts with the ASBT-FXR reporter assay. As indicated by Fig. 6D , lpAsbt can transport lamprey bile salts from its liver lipid extract and 5 ␣ -cyprinol sulfate (1 M), another 5 ␣ -C27 bile alcohol, but not modern 5 ␤ -C24 bile salts, including tauroursodeoxycholic acid (TUDCA), taurochenodeoxycholic acid (TCDCA), TCA, glycocholic acid, and glycoursodeoxycholic acid. Interestingly, glycochenodeoxycholic acid (GCDCA) is an exception and apparently was transported by lpAsbt. skAsbt transported scymnol sulfate in addition to all the lpAsbts substrates, but again demonstrated low affi nity for most modern bile salts ( Fig.  6D ) . In contrast, all tested bile salts were effectively transported by hASBT. Collectively, these fi ndings indicate that lpAsbt's affi nity for bile salts is largely confi ned to the 5 ␣ -C27 early evolving "ancient" bile salts, skAsbt can effectively transport both the "ancient" and evolutionarily "intermediate" bile salts whereas hASBT effectively transports bile salts with the entire spectrum of structures.
Substrate specifi city of skAsbt is confi ned to bile salts, similar to hASBT
To further assess skAsbt substrate specifi city, we tested an array of bile salts, steroid sulfates, and organic anions in assays competing with uptake of 3 H-TCA. In general, more bile salt structures inhibited hASBT 3 H-TCA uptake more effectively than with skAsbt ( Fig. 7 ) . Specifi cally, the early evolved bile salts (5 ␣ -PZS, 5 ␣ -cyprinol sulfate), "intermediate" bile salts (5 ␤ -C27 scymnol sulfate) and modern 5 ␤ -C24 bile acids (TCDCA, GCDCA, taurolithocholic acid, and taurolithocholic acid -3-sulfate) signifi cantly reduced 3 H-TCA transport activity in both skAsbt and hASBT. Interestingly, TUDCA effectively reduced 3 H-TCA transport
Bile salt substrate affi nity is limited to early evolving bile salts for lpAsbt, early and "intermediate" bile salts for skAsbt, whereas hASBT has high affi nity for all bile salt forms
To test if lpAsbt transports bile salts, we utilized a luciferase-based ASBT-FXR reporter assay. Because conjugated bile salts require a specifi c transporter (e.g., ASBT) to cross the cell membrane and they are ligands for human FXR, transactivation of FXR refl ects the ability of ASBT to transport a given bile salt into the transfected cells. In this experiment, expression constructs of lpAsbt, skAsbt, hASBT, or empty vector were cotransfected with FXR reporter constructs into HEK293T cells. The transfected cells were then treated with 5 ␣ -PZS, scymnol sulfate, and TCA, the three major bile salts in lamprey, skate, and human, respectively. Interestingly, lpAsbt cotransfection transactivated FXR after 5 ␣ -PZS treatment, indicating lpAsbt does transport this endogenous bile salt ( Fig. 6A ). SkAsbt and hASBT also demonstrated transport activity represent early evolving members of vertebrate evolution, and compared these with the human system. Our results demonstrate that primitive ASBT/SLC10A2 orthologs in lamprey and skate have the ability to transport bile salts ( Figs. 2, 5, and 6 ). Like mammalian ASBT/Asbt, the substrate specifi city of lpAsbt and skAsbt appears confi ned to bile salts, as they did not demonstrate affi nity for structurally related steroid sulfates and other organic anions (Fig. 7) . The mRNA tissue distribution of both lpAsbt and skAsbt was most abundant in the distal intestine and kidney ( Fig. 4 ) , consistent with the development of transporters to reabsorb bile salts from the intestinal lumen, an essential function for establishing an enterohepatic circulation. This molecular evidence indicates that the enterohepatic circulation of bile salts was present at the earliest beginnings of vertebrate evolution. Because an ASBT ortholog was not identifi ed in the sea squirt ( Fig. 2 and supplementary Fig. I) , a late nonvertebrate, we propose that ASBT/ Asbt is a bile salt transporter that evolved at the beginning of vertebrate evolution. We also demonstrated that skAsbt transports bile salts in a Na + -dependent manner. At this time, we were not able to directly determine whether bile salt transport by lpAsbt is Na + -dependent since appropriate radiolabeled bile salt substrates are not available. However, protein sequence alignment reveals that amino acids directly involved in Na + -binding for N. meningitidis Slc10a (Asbt-like) are completely conserved in lpAsbt, skAsbt, mammalian ASBT/ Asbt's and even Na + -dependent paralogs NTCP and SOAT (supplementary Fig. II) ( 15 ) , suggesting that lpAsbt is likely to be a Na + -dependent transporter.
In this study, we assessed transport activity and substrate specifi city with 3 H-TCA uptake assays in intact intestinal tissue ( Fig. 2 ) and cell-based assays as well as in ASBT-FXR reporter assays using recombinant expressed transporters ( Figs. 5 and 6 ). Collectively, these assays demonstrate that lpAsbt has a bile salt substrate specifi city with high affi nity only for 5 ␣ -PZS (the endogenous bile salt of lamprey) and 5 ␣ -cyprinol sulfate, two early evolving "ancient" 5 ␣ bile alcohols, whereas the more evolutionarily advanced "intermediate" 5 ␤ -C27 bile alcohol scymnol sulfate was a low affi nity substrate. In contrast, the modern 5 ␤ -C24 bile acids TCA and TCDCA were not transported. In the case of skAsbt, not only was 5 ␤ -C27 scymnol sulfate (its endogenous bile salt) a high affi nity substrate but so were the "ancient" 5 ␣ -bile alcohols. The later evolving 5 ␤ -C24 bile acids such as TCA and TCDCA showed only low affi nity for skAsbt. Surprisingly, all the structural forms of bile salts were high affi nity substrates for hASBT, even though the major endogenous bile salts in humans are 5 ␤ -C24 bile acids. Altogether, these results suggest that ASBT expanded its substrate specifi city whenever a novel class of bile salts emerged in evolution ( 1, 11 ) .
This broad substrate affi nity for human ASBT is unusual, as most orthologs generally lose affi nity for their earlier substrates when they acquire affi nity for novel substrates during evolution ( 24-26 ), a phenomenon termed "ligand-receptor" coevolution. ASBT/Asbt has apparently retained affi nity for old substrates even as it gained affi nity activity in hASBT but not in skAsbt, consistent with results from the ASBT-FXR reporter assay. Taurodehydrocholic acid had no effect on 3 H-TCA transport activity with either skAsbt or hASBT. We then determined the affi nity of skAsbt for 5 ␤ -C27 scymnol sulfate, the major endogenous bile salt in skate, in a competition assay for 3 H-TCA uptake. Scymnol sulfate has a K i of 42 ± 12 µM, whereas the K m for 3 H-TCA was calculated as 87 ± 38 µM (supplementary Fig. V) .
In addition, we tested whether or not steroid sulfates could inhibit hASBT and skAsbt transport of 3 H-TCA. These molecules are structurally similar to bile salts and are transported by SOAT/SLC10A6 ( 23 ), a close paralog of ASBT ( Fig. 3 ) . Neither pregnenolone-3-sulfate nor dehydroepiandrosterone-3-sulfate inhibited uptake activity of hASBT and skAsbt for 3 H-TCA. Estradiol-3-sulfate weakly inhibited skAsbt but not hASBT, whereas estrone-3-sulfate weakly inhibited hASBT but not skAsbt. However, 3 H-estrone-3-sulfate (25 M) was not transported by lpAsbt, skAsbt, or hASBT. Also, both skAsbt and hASBT did not show signifi cant affi nity for the organic anion bilirubin-ditaurate, whereas bromosulfophtalein signifi cantly inhibited both transporters. Taken together, these competition experiments suggest that even as the substrate specifi city of these transporters expanded for bile salts, this expansion did not extend to the closely related family of steroid sulfates.
DISCUSSION
In order to explore the evolutionary development of ASBT/SLC10A2 and its substrate specifi city, we functionally characterized this intestinal bile salt transport system in the sea lamprey and the little skate, two species that for more modern bile salts. We speculate that modern ASBT/Asbt retains its broad substrate specifi city in order to recover as many different species of bile salts as possible. In mammals, 16 different enzymatic reactions are required to convert cholesterol to 5 ␤ -C24 bile acids. As each step is not 100% effi cient, small amounts of intermediate bile salts will be produced and excreted in to bile ( 27 ) . In order to most effi ciently maintain the bile salt pool size, these "by-products of bile salt synthesis" are also reclaimed. We speculate that other transporters involved in the enterohepatic circulation of bile salts might also retain specifi city for a wide variety of bile salt substrates structures, although this hypothesis has not yet been tested.
Our phylogenetic analysis indicates that the recently solved crystal structure of N. meningitidis Slc10a (formally called nmASBT) is not a member of the SLC10A2 gene family ( Fig. 3 ) . Although it transports TCA, it is not known whether it can transport other bile salts or other molecules. In addition, N. meningitidis Slc10a shares lower identity to hASBT than does SLC10A3, SLC10A4, SLC10A5, and SOAT/SLC10A6 (supplementary Table II ). Because the latter four solute carriers do not transport TCA, this raises a question as to the specifi city of the substrate binding pocket of N. meningitidis Slc10a for bile salts. Because lpAsbt, skAsbt, and hASBT share much higher sequence identity and demonstrate differential selectivity for bile salts, it should be possible to identify specifi c amino acids that are responsible for the expansion of mammalian ASBT/Asbt substrate specifi city using further sequence analyses and mutation experiments. Doing so will help to determine ASBT/Asbt's evolutionary path while providing insight into the structurefunction determinants of hASBT.
In conclusion, the present study demonstrates that Asbt is a functional bile salt transporter in the most primitive vertebrates, occurring together with the emergence of bile salts and the ability of organisms to form bile. This study establishes that ASBT/Asbt and the enterohepatic circulation of bile salts were present at the beginning of vertebrate evolution, giving vertebrates the transport ability essential to regulate both bile salt and lipid homeostasis. Our fi ndings also suggest that as ASBT evolved, it gained substrate specifi city to novel bile salt structures while retaining affi nity for its old substrates.
